STAGE IV PROSTATE ADENOCARCINOMA AJCC V7
Clinical trials for STAGE IV PROSTATE ADENOCARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV PROSTATE ADENOCARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IV PROSTATE ADENOCARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for tough prostate cancer
Disease control OngoingThis study tests whether adding cediranib to olaparib works better than olaparib alone for men with a type of advanced prostate cancer that has spread and no longer responds to hormone therapy. About 90 men will take part. The goal is to see if the combination slows cancer growth…
Matched conditions: STAGE IV PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 09:01 UTC
-
Can prostate removal boost survival in advanced cancer?
Disease control OngoingThis study tests whether surgically removing the prostate, along with hormone therapy and possibly chemotherapy, helps men with prostate cancer that has spread to other parts of the body. About 190 men with newly diagnosed metastatic prostate cancer will be randomly assigned to r…
Matched conditions: STAGE IV PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated May 26, 2026 08:56 UTC
-
New combo therapy aims to stop returning prostate cancer in its tracks
Disease control OngoingThis study looks at whether adding a drug called apalutamide to standard radiation therapy can better control prostate cancer that has come back after surgery. About 324 men with a rising PSA after prostate removal will receive either radiation plus apalutamide or radiation plus …
Matched conditions: STAGE IV PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New hope for tough prostate cancer: drug cocktail trial underway
Disease control OngoingThis study tests different combinations of approved drugs to treat men with advanced prostate cancer that has spread and no longer responds to hormone therapy. About 196 men will receive either a standard hormone-blocking combo or that combo plus an immunotherapy or chemotherapy …
Matched conditions: STAGE IV PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Double-Drug attack shows promise for tough prostate cancer
Disease control OngoingThis study tests whether adding a chemotherapy drug (cabazitaxel) to a hormone therapy (abiraterone) works better than hormone therapy alone for men with advanced prostate cancer that has spread and stopped responding to initial treatment. About 223 men who have already received …
Matched conditions: STAGE IV PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 22, 2026 13:55 UTC